0.2071
0.15%
0.0003
Vincerx Pharma Inc Azioni (VINC) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses |
35.15%
7.478
|
5.533 | 10.32 | 11.66 | 15.10 |
Operating Income/Loss |
35.15%
-7.478
|
-5.533 | -10.32 | -11.66 | -15.10 |
Nonoperating Income/Loss |
949.23%
-4.951
|
0.583 | 0.602 | 0.509 | 0.758 |
Income/Loss From Continuing Operations Before Tax |
151.09%
-12.43
|
-4.95 | -9.715 | -11.15 | -14.34 |
Income/Loss From Continuing Operations After Tax |
151.09%
-12.43
|
-4.95 | -9.715 | -11.15 | -14.34 |
Net Income/Loss
|
151.09%
-12.43
|
-4.95 | -9.715 | -11.15 | -14.34 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
82,208%
0.0214
|
0.000026 | 0.0213 | 0.0213 | 0.0212 |
Diluted Average Shares |
82,208%
0.0214
|
0.000026 | 0.0213 | 0.0213 | 0.0212 |
Basic Earnings Per Share |
152.17%
-0.58
|
-0.23 | -0.46 | -0.52 | -0.68 |
Diluted Earnings Per Share |
152.17%
-0.58
|
-0.23 | -0.46 | -0.52 | -0.68 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):